Literature DB >> 20232472

Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree.

Sheng-Hua Wu1, Pei-Ling Yin, Yong-Mei Zhang, Hui-Xian Tao.   

Abstract

OBJECTIVES: To investigate the expressions of 15-lipoxygenase (15-LO) and 5-lipoxygenase (5-LO) in leukocytes and the changes of blood lipoxin A(4)(LXA(4)), leukotriene (LT)B(4) and LTC(4) in children with asthma, and to explore the relationship between the blood eicosanoids and one of serum high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-5, IL-8 and IL-13 and IgE in children with asthma. STUDY
DESIGN: One hundred six asthmatic children were divided into three groups, that is, mild persistent asthmatic group, moderate persistent asthmatic group and severe persistent asthmatic group. Forty healthy children were served as controls.
METHODOLOGY: The expressions of 15-LO and 5-LO mRNA in leukocytes were assessed by reverse transcription-polymerase chain reaction, and the blood LXA(4), LTB(4), LTC(4), IL-5, IL-8, and IL-13 were determined with enzyme-linked immunosorbent assay. Serum hsCRP was determined with latex-enhanced immuno-turbidimetry kits.
RESULTS: The leukocytic 15-LO expression and blood LXA(4) were gradually decreased, and the leukocytic 5-LO expression, blood LTB(4), LTC(4), IL-5, IL-8, IL-13, and hsCRP were gradually increased in children with asthma from mild degree to moderate and severe degree. There were positive correlations between blood LXA(4) and one of the peak expiratory flow (PEF) and forced expiratory volume in 1 sec (FEV(1)) percent-predicted values, and negative correlations between blood LTC(4) and one of the PEF and FEV(1) percent-predicted values in children with asthma. There were negative correlations between blood LXA(4) and one of the IL-5, IL-8, IL-13, and hsCRP levels, and positive correlations between one of blood LTB(4), LTC(4) and one of the IL-5, IL-8, IL-13 and hsCRP levels in children with asthma.
CONCLUSIONS: The reversed changes between 15-LO, its product LXA(4) and 5-LO, its products LTB(4) and LTC(4) in children with asthma from mild, moderate to severe degree were found, suggesting that insufficient generation of LXA(4) and overproduction of LTs may be the reason for the asthmatic children whose illness become more serious.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232472     DOI: 10.1002/ppul.21186

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  12 in total

1.  Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus.

Authors:  Rashed A Hasan; Edmund OʼBrien; Peter Mancuso
Journal:  Pediatr Crit Care Med       Date:  2012-03       Impact factor: 3.624

2.  Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.

Authors:  Sheng-Hua Wu; Xiao-Qing Chen; Xia Kong; Pei-Ling Yin; Ling Dong; Pei-Yuan Liao; Jia-Ming Wu
Journal:  World J Pediatr       Date:  2015-04-06       Impact factor: 9.186

3.  Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.

Authors:  Wanda Phipatanakul; David T Mauger; Ronald L Sorkness; Jonathan M Gaffin; Fernando Holguin; Prescott G Woodruff; Ngoc P Ly; Leonard B Bacharier; Nirav R Bhakta; Wendy C Moore; Eugene R Bleecker; Annette T Hastie; Deborah A Meyers; Mario Castro; John V Fahy; Anne M Fitzpatrick; Benjamin M Gaston; Nizar N Jarjour; Bruce D Levy; Stephen P Peters; W Gerald Teague; Merritt Fajt; Sally E Wenzel; Serpil C Erzurum; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

4.  Exhaled breath condensate eicosanoid levels associate with asthma and its severity.

Authors:  Shamsah Kazani; Anna Planaguma; Emiko Ono; Matteo Bonini; Muhammad Zahid; Gautham Marigowda; Michael E Wechsler; Bruce D Levy; Elliot Israel
Journal:  J Allergy Clin Immunol       Date:  2013-04-19       Impact factor: 10.793

Review 5.  Resolution of inflammation in asthma.

Authors:  Bruce D Levy; Isabelle Vachier; Charles N Serhan
Journal:  Clin Chest Med       Date:  2012-07-25       Impact factor: 2.878

6.  Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.

Authors:  Xia Kong; Sheng-Hua Wu; Li Zhang; Xiao-Qing Chen
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

Review 7.  Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.

Authors:  Rafael I Jaén; Sergio Sánchez-García; María Fernández-Velasco; Lisardo Boscá; Patricia Prieto
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 8.  Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids.

Authors:  Eva Knuplez; Eva Maria Sturm; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

9.  Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways.

Authors:  Bruce D Levy
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

Review 10.  Innate immunity is a key factor for the resolution of inflammation in asthma.

Authors:  Cindy Barnig; Bruce D Levy
Journal:  Eur Respir Rev       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.